“Gene-Targeted Antimicrobial Strategies Using CRISPR-Cas Systems Against Multidrug-Resistant Bacterial Pathogens”, Int. j. appl. clin. res., vol. 3, no. 2, pp. 40–47, Jun. 2025, doi: 10.66222/ytjfrx35.